المؤلفون: Wang, Lihong, Wang, Xiaosa, Wu, Yangyang, Wang, Jingjing, Zhou, Wenping, Wang, Jianyao, Guo, Haoran, Zhang, Na, Zhang, Lufang, Hu, Xuanyu, Zhao, Yuanyuan, Miao, Jinxin, Zhang, Zifang, Chard Dunmall, Louisa S., Zhang, Danhua, Lemoine, Nicholas R., Cheng, Zhenguo, Wang, Yaohe

المصدر: In Cancer Letters 1 August 2023 568

المؤلفون: Cao, Dujuan, Song, Qianqian, Li, Junqi, Chard Dunmall, Louisa S., Jiang, Yuanyuan, Qin, Bin, Wang, Jianyao, Guo, Haoran, Cheng, Zhenguo, Wang, Zhimin, Lemoine, Nicholas R., Lu, Shuangshuang, Wang, Yaohe

المصدر: In Molecular Therapy - Oncolytics 16 June 2022 25:264-275

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Wenyi Yan, Chard Dunmall, Louisa S., Lemoine, Nicholas R., Yaohe Wang, Yafeng Wang, Pengju Wang

المصدر: Frontiers in Immunology; 2023, p1-14, 14p

مصطلحات موضوعية: CANCER cells, T cells, CANCER treatment, TUMOR antigens, LYMPHOCYTE subsets

المؤلفون: Zhang, Na, Wu, Yangyang, Wu, Yifan, Wang, Lihong, Chen, Jingfei, Wang, Xiaosa, Chard Dunmall, Louisa S., Cheng, Zhenguo, Wang, Yaohe

المصدر: Cells (2073-4409); Jul2022, Vol. 11 Issue 14, pN.PAG-N.PAG, 20p

مصطلحات موضوعية: SOMATIC mutation, OVERALL survival, NON-small-cell lung carcinoma, DRUG target, RANDOM forest algorithms, GENE expression profiling

المؤلفون: Wang, Zhizhong, Cheng, Zhenguo, Lu, Shuangshuang, Chard Dunmall, Louisa S., Wang, Jun, Guo, Yongjun, Wang, Yaohe

المصدر: Frontiers in Immunology; 6/22/2022, Vol. 13, p1-12, 12p

مصطلحات موضوعية: B cells, PROGNOSIS, ESOPHAGEAL cancer, SQUAMOUS cell carcinoma, PLASMA cells, IMMUNOGLOBULIN heavy chains

المؤلفون: Ferguson, Mark S., Chard Dunmall, Louisa S., Gangeswaran, Rathi, Marelli, Giulia, Tysome, James R., Burns, Emily, Whitehead, Maria A., Aksoy, Ezra, Alusi, Ghassan, Hiley, Crispin, Ahmed, Jay, Vanhaesebroeck, Bart, Lemoine, Nicholas R., Wang, Yaohe

المصدر: Molecular Therapy; May 2020, Vol. 28 Issue: 5 p1263-1275, 13p

المؤلفون: Zhao Y; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention & Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China., Chard Dunmall LS; Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Cheng Z; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention & Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China., Wang Y; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention & Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.; Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Si L; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention & Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.

المصدر: Frontiers in pharmacology [Front Pharmacol] 2022 Nov 01; Vol. 13, pp. 1036502. Date of Electronic Publication: 2022 Nov 01 (Print Publication: 2022).

نوع المنشور: Systematic Review

بيانات الدورية: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

المؤلفون: Sun Y; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China., Zhang Z; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China., Zhang C; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China., Zhang N; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China., Wang P; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China., Chu Y; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China., Chard Dunmall LS; Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Lemoine NR; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China.; Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Wang Y; National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China.; Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.

المصدر: Molecular therapy oncolytics [Mol Ther Oncolytics] 2022 Jun 06; Vol. 26, pp. 105-119. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE

المؤلفون: Wang L; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention and Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China., Chard Dunmall LS; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK., Cheng Z; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention and Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China., Wang Y; National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention and Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China yaohe.wang@qmul.ac.uk.; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 May; Vol. 10 (5).

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms* , Oncolytic Virotherapy*/methods , Oncolytic Viruses*, Humans ; Immunotherapy ; Tumor Microenvironment